surpass 5 tirzepatide SURPASS-5 Data: Plus Insulin Glargine Improve Glycemic Control in T2D New research from the SURPASS-EARLY
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
New research from the SURPASS EARLY trial found that tirzepatide improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes. Changes from baseline body weight to end of treatment in SURPASS 1 5 Download Scientific Diagram Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme Bergman 2025 Diabetes, Obesity and Metabolism Wiley Online Library Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes: A Perspective for Primary Care Providers PMC
Store: matisco.be · Domain: matisco.be


























